- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by COUR Pharmaceuticals Development Company, Inc.
Total 533 results
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPost Traumatic Stress DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSmoking CessationUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney Disease (ADPKD)Germany, Italy, Belgium, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBorderline Personality DisorderUnited States, Spain, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedDrug-drug InteractionAustralia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTourette's DisorderGermany, United States, Bulgaria, Romania, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTourette's DisorderUnited States, Taiwan, Korea, Republic of, Mexico, Canada, Hungary
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTourette's DisorderUnited States, Germany, Taiwan, Korea, Republic of, Mexico, Hungary, Bulgaria, Ukraine, Romania, Canada
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedTourette's Disorder (TD)United States, Canada, Hungary
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney DiseaseNetherlands
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAutosomal Dominant Polycystic Kidney DiseaseUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedAtrial Fibrillation | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationUnited States, Italy, Germany, Netherlands, Spain, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, France, Poland, Canada, Slovakia
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMajor Depressive DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMajor Depressive DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Bulgaria, Philippines, Romania, Russian Federation, Serbia, Croatia, India, Korea, Republic of, Slovakia, Taiwan, Ukraine
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAcute SchizophreniaKorea, Republic of, United States, Serbia, Ukraine, Romania, Poland, Canada, Latvia, Japan
-
Otsuka Pharmaceutical Development & Commercialization...CompletedTic Disorder | Tourette's DisorderUnited States, Canada, Hungary, Italy
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMultiple MyelomaUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAtopic DermatitisUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I DisorderCanada
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedDrug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I DisorderBipolar DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaKorea, Republic of, United States, Estonia, Italy, Hungary, Bulgaria, Croatia, France, Poland, Thailand, Puerto Rico, Chile, South Africa, Austria, Belgium
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, Argentina, Bulgaria, India, Malaysia, Mexico, Philippines, Romania, Russian Federation, Serbia, Slovakia, Taiwan
-
Otsuka Pharmaceutical Development & Commercialization...CompletedCongestive Heart FailureUnited States
-
AcelRx Pharmaceuticals, Inc.U.S. Army Medical Research and Development CommandCompletedModerate-to-severe Acute PainUnited States
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...RecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Active, not recruitingImmunoglobulin A NephropathyUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMajor Depressive DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention-deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAgitation in Participants With Dementia of the Alzheimer's TypeUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...Completed